Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bridging Study Using ch14.18/CHO Antibody in Children With Refractory Neuroblastoma

NCT01704872 is registered in ClinicalTrials.gov with St. Anna Kinderkrebsforschung as lead sponsor.

NCT NCT01704872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01704872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bridging Study Using ch14.18/CHO Antibody in Children With Refractory Neuroblastoma
Lead sponsor
St. Anna Kinderkrebsforschung
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2005
Completion date
March 31, 2012
Enrollment
16 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma